Beta Carophyllene
What is it: A specialized CB2 receptor agonist targeting chronic inflammatory processes- ⬤ Minimal research: Very little scientific study exists, with no or very few peer-reviewed studies. Insufficient data for conclusions.
- ⬤⬤ Limited research: Few studies exist, mostly small trials or case reports. Findings are preliminary and lack strong validation.
- ⬤⬤⬤ Moderately researched: Multiple studies, including mid-sized trials, exist. Some findings are replicated, but more research is needed.
- ⬤⬤⬤⬤ Well-researched: Supported by substantial evidence, including at least one large trial or meta-analysis.
- ⬤⬤⬤⬤⬤ Extensively studied: Numerous large studies and meta-analyses exist. Findings are widely accepted with strong scientific consensus.
- ⬤ Extremely Difficult to Access: Rare, experimental, or highly specialized. Requires multiple referrals, long wait times, travel, and strict follow-up.
- ⬤⬤ Difficult to Access: Limited to select centers with moderate barriers. Requires referral, potential travel, and wait times of weeks to months.
- ⬤⬤⬤ Moderately Accessible: Available in larger hospitals or clinics. Requires a basic referral, with moderate wait times and some coordination.
- ⬤⬤⬤⬤ Easy to Access: Widely available in most clinics. Minimal referral, short wait times, and simple preparation or follow-up.
- ⬤⬤⬤⬤⬤ Trivial to Access: Easily found in pharmacies or clinics. No referral needed, minimal wait, and straightforward access.
- ⬤ Up to $100
- ⬤⬤ Up to $500
- ⬤⬤⬤ Up to $2000
- ⬤⬤⬤⬤ Up to $10,000
- ⬤⬤⬤⬤⬤ More than $10,000
To calculate the reported effectiveness for a patient view, the model first analyses whether it can be ascertained that the person writing the review has had direct experience of the treatment for themselves or a loved one. If so, it then uses sentiment analysis to rate their view from 1-5 on how effective this treatment was for them, with 1 being the least effective, and 5 the most effective.
1 Research paper
Referenced in this guide
2 Patient views
Contributed in this guide
Figure out what Beta Carophyllene means for you
Page contents
Basics: What you need to know
Beta-caryophyllene is a bicyclic sesquiterpene that selectively activates the CB2 receptor and is found in plants such as black pepper, cloves, and cannabis. In a purified, standardized formulation, it is being researched for its potential to reduce chronic inflammation and regulate immune responses. Studies suggest it may help address ongoing symptoms in those experiencing persistent effects of certain viral illnesses, thanks to its targeted receptor activity and immunomodulatory properties. Although more data is needed, this formalized treatment approach aims to tap into the compound’s anti-inflammatory benefits without relying on broader plant extracts.
History and development
- Identification milestone: In the early 20th century, scientists recognized the compound’s distinct bicyclic structure in plant oils, but its broader therapeutic value wasn’t fully realized until later.
- Cannabinoid recognition: In 2008, researchers led by Dr. Andreas Gertsch identified this compound as a dietary cannabinoid with a strong affinity for the CB2 receptor.
- Therapeutic focus: Over the past decade, increasing attention has been placed on the compound’s immunomodulatory potential, leading to research on refined beta-caryophyllene formulations.
What is known
- Anti-inflammatory effect: By selectively targeting CB2 receptors, it may reduce production of pro-inflammatory molecules and support healthier immune regulation.
- Immunomodulatory potential: Early indications suggest it can alter immune cell behavior, possibly helping manage chronic immune overactivation.
- Antioxidant activity: Lesser-known research points to mild antioxidant benefits that could protect tissues from oxidative stress.
- Influences gut health: Some studies indicate it may help balance gut flora, potentially important for overall immune function.
- Risk of symptom flare: In certain individuals, changes in immune activity can trigger unexpected responses, emphasizing the need for close medical guidance.
What is not known
- Precise dosage guidelines: While small-scale trials exist, standardized dosing regimens and duration remain uncertain.
- Exact mechanism details: Its anti-inflammatory pathways are not fully mapped, leaving some processes open to further exploration.
- Long-term impacts: Research on extended use is limited, so potential risks or cumulative effects are not clearly defined.
- Drug interactions: Interactions with other medications, especially those affecting the immune system, have not been conclusively studied.
- Population-specific outcomes: It is unclear whether different demographics, such as older adults or those with coexisting ailments, respond differently.
- Activates CB2 receptors: Selectively binds to reduce inflammatory signals.
- Regulates immune function: Helps balance different immune mediators.
- Supports tissue health: Potential antioxidant effects protect cells from damage.
- Targets overactivation: Could disrupt excessive immune responses.
- Enhances specific cellular pathways: Modulates protein signaling cascades related to inflammation.
- Mild GI discomfort: Nausea or upset stomach in certain users.
- Allergic reactions: Rare, but possible in sensitive individuals.
- Interaction concerns: Potential interference with immune-modulating medications.
- Unknown long-term risks: Extended use not fully studied.
- Possible sedation: Minor drowsiness reported in some cases.
- Limited clinical data: Supporters see promise but want larger trials.
- Mechanistic uncertainty: Debate exists about how precisely it moderates immune activity.
- Regulatory complexity: Its association with cannabis compounds adds policy hurdles.
- Variable patient response: Outcomes can be inconsistent, leading to differing viewpoints.
- Long-term unknowns: Some professionals prefer caution due to limited efficacy data.
Patient views
Experiences
- Patients appreciate beta-caryophyllene's ability to activate CB2 receptors without causing intoxication.
- Some find it helpful for managing fatigue and nervous system stress.
- It is preferred for daily health use over THC due to its non-intoxicating nature.
Challenges
- Some patients experience overstimulation or emotional dysregulation with certain herbs, though beta-caryophyllene is not explicitly mentioned as causing this.
- No direct negative feedback about beta-caryophyllene was noted.
Tips
- Consider using beta-caryophyllene for CB2 receptor activation without intoxication.
- Pair beta-caryophyllene with other calming supplements like magnesium or lemon balm.
To calculate the reported effectiveness for a patient view, the model first analyses whether it can be ascertained that the person writing the review has had direct experience of the treatment for themselves or a loved one. If so, it then uses sentiment analysis to rate their view from 1-5 on how effective this treatment was for them, with 1 being the least effective, and 5 the most effective.
Patient view
I use cannabis recreationally but what really helped me (with fibromyalgia fatigue) was beta-caryophyllene. I used a couple of different ones started with CB2 Hemp seed oil, but now just take a couple of drops of the CB2 Wellness tincture. Both from a brand called Cannanda.
September 2024 • /r/LongCovid
Patient view
I like BCP because it has the cb2 receptor activation but not the cb1 activation so you don’t feel intoxicated (THC activates both receptors, and it’s turn cb1 that gets you high, but the cb2 that provides most of there benefits).
I personally like using cannabis for the high recreationally, but for daily health use, I use BCP.
August 2024 • /r/LongCovid
What and who it targets
Chronic inflammation sufferers
Targets inflammation pathways effectively.
Neurological symptom patients
Addresses brain fog and cognitive issues.
Pain management candidates
Provides relief for chronic pain.
Immune dysregulation cases
Modulates immune system responses.
Relevant research
How much evidence on this?
- Few studies, including one open-label trial.
- Studied for long COVID since 2022.
- Single-site study with 51 participants.
- No large-scale trials or meta-analyses yet.
Research focusing on
- Reduced symptoms in 72-84% of participants.
- No significant adverse effects reported.
- Synergistic effects with pregnenolone noted.
- Focus on inflammation and neurological symptoms.
What needs more research?
- Long-term effects remain unclear.
- Mechanism of action in humans not fully understood.
- Efficacy in diverse populations untested.
- Optimal dosage and combinations need exploration.
- ⬤ Minimal research: Very little scientific study exists, with no or very few peer-reviewed studies. Insufficient data for conclusions.
- ⬤⬤ Limited research: Few studies exist, mostly small trials or case reports. Findings are preliminary and lack strong validation.
- ⬤⬤⬤ Moderately researched: Multiple studies, including mid-sized trials, exist. Some findings are replicated, but more research is needed.
- ⬤⬤⬤⬤ Well-researched: Supported by substantial evidence, including at least one large trial or meta-analysis.
- ⬤⬤⬤⬤⬤ Extensively studied: Numerous large studies and meta-analyses exist. Findings are widely accepted with strong scientific consensus.
Research
This study explored the effects of a dietary supplement containing β-caryophyllene, pregnenolone, and seven other compounds on symptoms of long COVID. Researchers conducted a one-arm open-labeled study with 51 participants from 18 states, who tracked the severity of 12 symptoms over a 4-week period.
The study found that all symptoms, including fatigue, neurological issues, and shortness of breath, were significantly reduced after 2 weeks, with further improvement by 4 weeks. Between 72% and 84% of participants experienced noticeable symptom relief, and no significant adverse effects were reported.
For individuals dealing with long COVID, this study suggests that the nutraceutical formulation could be a safe and effective way to alleviate a wide range of symptoms. It offers hope for improving quality of life in the absence of other dedicated treatments.
The study is moderately reliable as it was published in a reputable journal, 'Frontiers in Nutrition,' and involved 51 participants. However, the one-arm design and lack of a control group limit the strength of its conclusions.
November 2022 • Frontiers in nutrition
Accessibility
- ⬤ Extremely Difficult to Access: Rare, experimental, or highly specialized. Requires multiple referrals, long wait times, travel, and strict follow-up.
- ⬤⬤ Difficult to Access: Limited to select centers with moderate barriers. Requires referral, potential travel, and wait times of weeks to months.
- ⬤⬤⬤ Moderately Accessible: Available in larger hospitals or clinics. Requires a basic referral, with moderate wait times and some coordination.
- ⬤⬤⬤⬤ Easy to Access: Widely available in most clinics. Minimal referral, short wait times, and simple preparation or follow-up.
- ⬤⬤⬤⬤⬤ Trivial to Access: Easily found in pharmacies or clinics. No referral needed, minimal wait, and straightforward access.
- ⬤ Up to $100
- ⬤⬤ Up to $500
- ⬤⬤⬤ Up to $2000
- ⬤⬤⬤⬤ Up to $10,000
- ⬤⬤⬤⬤⬤ More than $10,000
Method to access
- Purchase Beta Carophyllene products online from vendors like Amazon and True Terpenes.
- No prescription or referral is required.
- At-home use is possible with products such as capsules, oils, or isolates.
Cost
- Cannanda CB2 Wellness products: $39+ per bottle.
- True Terpenes Beta Caryophyllene isolate: $8–$700 depending on size.
- Amazon Caryophyllene capsules: $27.99 for 60 capsules.
- Prices vary by vendor and product type.
Insurance cover
- Insurance coverage for Beta Carophyllene products is not commonly available.
- Patients may need to consult their insurance providers for specifics.
- Coverage for Long Covid treatments generally varies by region and provider.
Locations
- Cannanda offers Beta Carophyllene products online.
- True Terpenes manufactures Beta Caryophyllene isolates in the USA.
- Amazon provides various Beta Carophyllene products globally.
- Specialized Long Covid clinics may not offer Beta Carophyllene as a standard treatment.
Frequently asked questions
Explore other treatments
It's a lot of information, isn't it?
Turnto's personal AI Assistant can help you figure out what this all means for you
© 2026 Turnto
